Literature DB >> 11895468

Endocrine abnormalities in healthy first-degree relatives of type 2 diabetes patients--potential role of steroid hormones and leptin in the development of insulin resistance.

P-A Jansson1, B Eliasson, S Lindmark, J W Eriksson.   

Abstract

BACKGROUND: First-degree relatives of type 2 diabetes patients are at risk of developing diabetes and they display several metabolic and hormonal perturbations. The interplay between insulin resistance, steroid hormones and circulating leptin is, however, still not fully explored in this group.
DESIGN: Thirty-three healthy first-degree relatives of type 2 diabetic patients (relatives; M/F 19/14) were compared to 33 healthy subjects without a family history of diabetes (controls) and the groups were matched for gender, age and body mass index (BMI). We performed euglycaemic hyperinsulinaemic clamps and blood was sampled for hormone analyses.
RESULTS: Relatives exhibited decreased insulin sensitivity (index of metabolic clearance rate of glucose; MCRI) but when genders were analysed separately, this difference was significant only in males (11.3 +/- 1.3 vs. 15.0 +/- 1.5 units, means +/- SEM, P = 0.030). In male relatives morning cortisol and testosterone levels were lower, whereas leptin was higher than in male controls (P = 0.018, 0.008 and 0.063, respectively). In male relatives plasma testosterone levels were significantly associated with insulin sensitivity (r = 0.48, P = 0.040). Circulating leptin levels were inversely correlated with insulin sensitivity in all subject groups (r-values -0.49 to -0.66; P < 0.05, except in female control subjects P = 0.063). These associations were present also when age and BMI or waist:hip ratio were included in stepwise multiple regression analyses.
CONCLUSION: Male subjects genetically predisposed for type 2 diabetes display several endocrine abnormalities including leptin, cortisol and testosterone levels. Dysregulation of these hormones may be important in the development of insulin resistance and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895468     DOI: 10.1046/j.1365-2362.2002.00963.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

Authors:  M Lundgren; M Svensson; S Lindmark; F Renström; T Ruge; J W Eriksson
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

2.  The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study.

Authors:  Jin Shang; Dahai Yu; Yamei Cai; Zheng Wang; Bin Zhao; Zhanzheng Zhao; David Simmons
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  Association between triglyceride glucose index and abnormal liver function in both urban and rural Chinese adult populations: Findings from two independent surveys.

Authors:  Lanfang Yu; Yamei Cai; Rui Qin; Bin Zhao; Xiaona Li
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

4.  Combined association of maternal and paternal family history of diabetes with plasma leptin and adiponectin in overweight Hispanic children.

Authors:  C Koebnick; L A Kelly; C J Lane; C K Roberts; G Q Shaibi; C M Toledo-Corral; J N Davis; M J Weigensberg; M I Goran
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

5.  Liver fat and SHBG affect insulin resistance in midlife women: the Study of Women's Health Across the Nation (SWAN).

Authors:  Kylie Kavanagh; Mark A Espeland; Kim Sutton-Tyrrell; Emma Barinas-Mitchell; Samar R El Khoudary; Rachel P Wildman
Journal:  Obesity (Silver Spring)       Date:  2013-05       Impact factor: 5.002

6.  Prostate cancer, insulin, and androgen deprivation therapy.

Authors:  P Stattin; R Kaaks
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.